CRISM Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 03 Jun 24 | BuyUK£2,316 | Gerry Beaney | Individual | 25,000 | UK£0.093 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 156,505 | 0.479% |
| General Public | 32,521,645 | 99.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 275.4%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 54,658 | UK£5.2k | 0% | no data | |||
| 39,808 | UK£3.8k | 0% | no data | |||
| 25,000 | UK£2.4k | 0% | no data | |||
| 19,797 | UK£1.9k | 0% | no data | |||
| 17,242 | UK£1.6k | 0% | no data |